1. A method for the in-vitro diagnosis andor risk stratification of heart diseases andor diseases of the lungs and respiratory tract selected from the group consisting of cardiac insufficiency, post myocardial infarction, pneumonia and exacerbated chronic obstructive pulmonary disease comprising
(a) contacting at least one sample of bodily fluid from a patient with an antibody specific for the polypeptide consisting of the amino acid sequence APETAVLGAELSAVGENGGEKPTPSPPWRLRRSKR (SEQ ID NO: 6), known as NT-proET-1,
(b) detecting binding of said antibody to NT-proET-1 using an immunoassay to determine the level of NT-proET-1 in said at least one sample, and
(c) diagnosing the presence or stratifying the risk of heart diseases andor diseases of the lungs and respiratory tract in the patient based on the result in steps (a) and (b), wherein the presence of a higher level of NT-proET-1 in said at least one sample compared to healthy controls indicates the presence of a heart disease or disease of the lungs and respiratory tract in said patient, or an increased risk of an unfavorable prognosis for heart disease or disease of the lungs and respiratory tract and wherein said heart disease or disease of the lungs and respiratory tract are selected from the group consisting of cardiac insufficiency, post myocardial infarction, pneumonia and exacerbated chronic obstructive pulmonary disease.
2. A method according to claim 1, characterized in that additionally a determination of at least one further marker is carried out, selected from the group of inflammatory markers, cardiovascular markers, neurohormonal markers, or ischemic markers.
3. A method according to claim 2, characterized in that the inflammatory marker is selected from at least one marker of the group of C-reactive protein (CRP), cytokines such as TNF-alpha, interleukines such as IL-6, procalcitonin (1-116, 3-116), and adhesion molecules such as VCAM or ICAM.
4. A method according to claim 2, characterized in that the cardiovascular marker is selected from at least one marker of the group creatine kinase, myoglobin, myeloperoxidase, natriuretic protein, particularly ANP (or ANF), proANP, NT-proANP, BNP, proBNP, NT-proBNP, or a partial sequence thereof, cardiac troponin, CRP, and also regulatory (pro)hormones, such as pro-gastrin releasing peptide (pro-GRP), pro-endothelin-2, pro-endothelin-3, pro-leptin, pro-neuropeptide Y, pro-somatostatin, pro-neuropeptide YY, pro-opionmelanocortin, pro-adrenomedullin (pro-ADM), pro-vasopressin (pro-AVP), or a partial sequence thereof.
5. A method according claim 2, characterized in that the ischemic marker is selected from at least one marker of the group troponin I and T, CK-MK.
6. A method according to claim 2, characterized in that the neurohormonal marker is at least one natriuretic protein, particularly ANP (or ANF), proANP, NT-proANP, BNP, proBNP, NT-proBNP, or a partial sequence thereof.
7. A method according to claim 2, characterized in that parallel or simultaneous determinations of the markers are carried out.
8. A method according to claim 1, characterized in that the determinations are carried out using an automatic analysis system, particularly by means of a Kryptor.
9. A method according to claim 1, characterized in that the determinations are carried out using a rapid test, particularly in individual or multiple parameter determinations.
10. The method of claim 1 wherein said antibody specific for NT-proET-1 binds to the area of NT-proET-1 comprised of SEQ ID NO: 2 or binds to the area of NT-proET-1 comprised of SEQ ID NO: 3.
11. The method of claim 10 wherein said antibody specific for NT-proET 1 binds to SEQ ID NO: 4, or said antibody specific for NT-proET-1 binds to SEQ ID NO: 5.
12. The method of claim 1, wherein said heart disease is cardiac insufficiency, and wherein the presence of a higher level of NT-pro-ET1, with a cut off value of 47.2 pmolml, in said at least one sample compared to healthy controls indicates the presence of chronic cardiac insufficiency in said patient.
13. The method of claim 1, wherein said heart disease is chronic cardiac insufficiency, and wherein the presence of more than 51.3 pmolml of NT-pro-ET1 in said at least one sample indicates an increased likelihood of death of said patient.
14. The method of claim 1, wherein said heart disease is cardiac insufficiency, and wherein the presence of a higher level of NT-pro-ET1, with a cut off value of 90.5 pmolml, in said at least one sample compared to healthy controls indicates the presence of acute cardiac insufficiency in said patient.
15. The method of claim 1, wherein said heart disease is acute cardiac insufficiency, and wherein the presence of more than 64 pmolml of NT-pro-ET1 in said at least one sample indicates an increased likelihood of death of said patient.
16. The method of claim 1, wherein said heart disease is post-myocardial infarction, and wherein the presence of more than 63.9 pmolml of NT-pro-ET1 in said at least one sample indicates an increased likelihood of rehospitalization of said patient due to cardiac insufficiency or death of said patient.
17. The method of claim 1, wherein said disease of the lungs and respiratory tract is pheumonia, and wherein the presence of more than 77 pmolml of NT-pro-ET1 in said at least one sample indicates an increased likelihood of death of said patient.
18. The method of claim 1, wherein said disease of the lungs and respiratory tract is exacerbated chronic obstructive pulmonary disease, and wherein the presence of a level of NT-proET-1 greater than 30.5 pmolml but less than 53 pmolml in said at least one sample indicates the presence of exacerbated chronic obstructive pulmonary disease in said patient.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. An optical-disc player, comprising:
a pair of optical-disc sensor levers (10) (15) respectively having a detection part capable of being embedded into the periphery of an optical disc (D) inserted into an optical-disc inserting opening (6) and rotating immediately once the detection part driven by the optical disc;
a conveying roller (35) used for clamping the optical disc on an optical-disc guide plate (21) and conveying the optical disc between the optical-disc inserting opening and a turntable (221) through the rotation of a motor (27);
a roller supporting component (36) used for supporting the conveying roller;
a driving member (37) embedded with the roller supporting component and used for driving the conveying roller and the optical-disc guide plate to be engaged and disengaged during the reciprocating motion;
a cam gear (26) used for moving the driving member;
a driving gear (30) used for driving the cam gear via a rotary force of the motor;
switches (13) (14) (38) used for controlling the rotation of the motor, and
a traverse mechanism (22) having a pick-up (25) and the turntable, wherein
the component is embedded with the roller supporting component and used for driving the conveying roller and the optical-disc guide plate to be engaged and disengaged, on the driving member being an E-shaped cam hole (37a); and
a convex portion (26e), a first toothed portion (26b) and a second toothed portion (26c) formed on the cam gear, and a toothless portion (26d) are formed between the two toothed portions;
the optical-disc player also comprising:
a shaking component (31) embedded onto the driving gear and shaking along with the rotation of the driving gear, and
a hook component (32) supported by the shaking component, wherein
the hook component has a contact portion (32b) capable of being embedded with the optical-disc sensor lever and a hook portion (32a) capable of being embedded with the convex portion of the cam gear;
when the optical disc taken out from the optical-disc inserting opening, the hook portion embedded with an end section (26p) of the convex portion by the disembedding between the optical-disc sensor lever and the contact portion; the cam gear driven to rotate by the shaking of the shaking component via the hook component and the driving gear engaged with the first toothed portion; the cam gear driven to rotate continuously and the driving member driven to move to a mobile terminal position, and then the conveying roller and the optical-disc guide plate disengaged from each other.
2. The optical-disc player according to claim 1, wherein the switches consist of a first switch (13) used for driving the motor to stop rotating when the optical disc is conveyed from a play position to the optical-disc inserting opening until the optical disc can be taken out, a second switch (14) used for starting the motor when the optical disc is taken out from the optical-disc inserting opening, and a third switch (38) used for driving the motor to stop rotating on a rotation terminal of the cam gear.
3. The optical-disc player according to claim 1, wherein the detection parts of the optical-disc sensor levers are arranged between the conveying roller and the turntable.
4. The optical-disc player according to claim 1, wherein the moving direction of the pick-up for the traverse mechanism is perpendicular to the optical-disc conveying direction.